RecallDepth
Class II Terminated

Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 30 Capsules per Bottle, Manufactured in Israel by: Teva Pharmaceutical IND, LTD, Jerusalem, Israel, Manufactured for: Teva Pharmaceuticals USA, Sellersville, PA, 18960, NDC 0093-7544-56

Company
Teva Pharmaceuticals Usa
Recall Initiated
March 4, 2014
Posted
April 9, 2014
Recall Number
D-1184-2014
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
324,648 Bottles
Firm Location
Horsham, PA, United States

Reason for Recall

Failed Tablet/Capsule Specifications: Teva Pharmaceuticals USA, is voluntarily recalling certain lots of Duloxetine DR Capsules USP, 20 mg, 30 mg & 60 mg due to a customer complaint trend regarding capsule breakage.

Distribution

Nationwide, Guam, Puerto Rico, American Samoa, Virgin Islands.

Lot / Code Info

Lot #: 50D003, Exp. 2/2015; 50D004, 50D005, Exp. 3/2015; 50D006, Exp. 5/2015; 50D010, Exp. 6/2015; 50D028, Exp. 9/2015; 50D029, 50D031, Exp. 10/2015; 50D032, 50D033, Exp. 11/2015

More recalls by Teva Pharmaceuticals Usa

View all recalls by this company →

Other recent Class II Drug recalls